Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

KIDS vs INMD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

INMD Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

INMD Overall Winner 6-Pillar Tally: KIDS 2 – 4 INMD Matrix Metrics: KIDS 4 – 6 INMD

As of Nov 19, 2026, InMode Ltd. (INMD) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas INMD carries 38.9/100 (SELL) at $12.70 (9.3x Forward P/E, 17.9% operating margin).

  • Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. INMD 38.9/100 SELL), INMD captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (17.9% vs. -8.2% operating margin) and revenue trajectory (-1.1% vs. +18.6% YoY).
  • Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile INMD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KIDS vs INMD
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86
INMD NASDAQ Head-to-Head Winner
InMode Ltd. Ordinary Shares
Electromedical & Electrotherapeutic Apparatus
$12.70
-1.4% 1D
Market Cap $741.2M
TTM Revenue $374M
Forward P/E 9.3x
Beta / 30D Vol 0.60β · 35% Vol
Unified Composite Score
38.9 / 100 SELL
Tech 23.0 Fund 53.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.2%), weak momentum, RSI 34
RSI-14: 34.3 · SMA20: $13.43 · SMA50: $13.94

6-Pillar Scorecard Institutional Category Breakdown (KIDS 2 – 4 INMD)

Columns: Metric · KIDS · INMD
1. Valuation Multiples INMD
Forward P/E N/M 9.3x
Trailing P/E N/M 10.8x
PEG Ratio N/M 2.90x
EV / Revenue 3.2x 0.9x
2. Growth & Scale KIDS
Revenue Growth (YoY) +18.6% -1.1%
Earnings Growth (YoY) +0.0% -5.9%
TTM Revenue (USD) $264M $374M
Market Cap $850.2M $741.2M
3. Profitability & Quality INMD
Gross Margin 73.8% 76.6%
Operating Margin -8.2% 17.9%
Net Profit Margin -12.8% 20.0%
Return on Equity (ROE) -9.8% 11.4%
4. Balance Sheet & Cash Flow INMD
Cash Generation (TTM) $1.1M EBITDA $69M
Cash Flow Margin 0.4% EBITDA Mgn 18.6%
Net Cash / Leverage $12.99 Book/Sh · -9.8% ROE $394M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning INMD
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 145.1% (100th %ile) 42.4% (14th %ile)
Put/Call OI Skew N/A 0.05x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 82.0% of Rev ($217M) 58.7% of Rev ($219M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KIDS (4) vs INMD (6)
Institutional Metric KIDS INMD Criterion Row Edge
Market Capitalization
Scale
$850.2M $741.2M Larger Scale KIDS
Trailing P/E Ratio
Valuation
N/M 10.8x Lower Multiple INMD
Forward P/E Ratio
Valuation
N/M 9.3x Lower Multiple INMD
Revenue Growth (YoY)
Growth
+18.6% -1.1% Higher Growth KIDS
Operating Margin (TTM)
Profitability
-8.2% 17.9% Higher Margin INMD
Net Profit Margin
Profitability
-12.8% 20.0% Higher Margin INMD
Return on Equity (ROE)
Capital Efficiency
-9.8% 11.4% Higher ROE INMD
52-Week Range Position
Momentum
90% ($14–$35) 2% ($13–$17) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
0.81β · 108% Vol 0.60β · 35% Vol Lower Realized Risk INMD
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 38.9 / 100 (SELL) Higher Composite KIDS
Trailing 12M Revenue (USD)
Operating Scale
$264M $374M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.8% 76.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev 2.90x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) $69M ($394M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +45.85 pp
KIDS: +36.37% · INMD: -9.48%
3M Horizon KIDS +42.41 pp
KIDS: +26.74% · INMD: -15.67%
6M Horizon KIDS +84.57 pp
KIDS: +76.4% · INMD: -8.17%
1Y Horizon KIDS +109.09 pp
KIDS: +98.84% · INMD: -10.25%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KIDS vs INMD. Trailing 12-month operating profitability (KIDS -8.2% vs INMD 17.9%) and valuation multiples (KIDS N/M vs INMD 9.3x Forward P/E) are benchmarked directly in Pillar 4 below.

KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M
INMD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$374M
Gross Margin76.6%
Op. Margin17.9%
ROE / Fwd P/E11.4% · 9.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
INMD CONSOLIDATION
89d in phase · OBV DISTRIBUTION
Current IV 42.4%
IV Percentile 14th %ile
Put/Call OI Skew 0.05x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact INMD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published
INMD Moat Profile Scale & Operating Efficiency Moat
Medical Devices Operator
Competes within the Medical Devices value chain with $741.2M market capitalization and 17.9% operating margin.
OpEx & R&D Reinvestment 58.7% of Rev ($219M)
90D Engineering Disclosures 0 Published

Investor FAQ KIDS vs INMD Key Questions & Quantitative Answers

As of Nov 19, 2026, InMode Ltd. (INMD) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas INMD carries 38.9/100 (SELL) at $12.70 (9.3x Forward P/E, 17.9% operating margin). Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. INMD 38.9/100 SELL), INMD captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (17.9% vs. -8.2% operating margin) and revenue trajectory (-1.1% vs. +18.6% YoY). Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile INMD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KIDS leads the Growth & Scale pillar: KIDS posts +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin), compared with INMD at -1.1% YoY revenue growth and -5.9% YoY earnings growth on $374M TTM revenue (76.6% gross margin, 17.9% operating margin). On trailing 12-month operating scale, KIDS generates $264M in USD-normalized revenue versus $374M for INMD. In operating R&D and SG&A reinvestment, KIDS deploys 82.0% of Rev ($217M) (0 90-day corporate R&D disclosures) versus 58.7% of Rev ($219M) (0 disclosures) for INMD.

INMD screens cheaper on headline valuation multiples. KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin), whereas INMD trades at 9.3x Forward P/E, 10.8x Trailing P/E, 2.90x PEG, and 0.9x EV/Revenue (18.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KIDS (-9.8% ROE) versus INMD (11.4% ROE) capital efficiency.

In options market volatility and institutional positioning, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk). By comparison, INMD carries 42.4% implied volatility (14th %ile, Compressed (<25th %ile)), a 0.05x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.60β · 35% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.